CSNK2A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.411800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.015000E-01
Normal-vs-Stage2
9.142400E-01
Normal-vs-Stage3
7.887800E-02
Normal-vs-Stage4
2.808800E-01
Stage1-vs-Stage2
6.521600E-01
Stage1-vs-Stage3
7.875700E-02
Stage1-vs-Stage4
1.843820E-01
Stage2-vs-Stage3
7.310100E-02
Stage2-vs-Stage4
2.240000E-02
Stage3-vs-Stage4
5.006100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.578600E-01
Normal-vs-AfricanAmerican
9.552800E-01
Normal-vs-Asian
3.125400E-01
Caucasian-vs-AfricanAmerican
8.896800E-01
Caucasian-vs-Asian
1.636600E-01
AfricanAmerican-vs-Asian
2.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.857000E-01
Normal-vs-Female
6.544400E-01
Male-vs-Female
3.648400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.597790E-01
Normal-vs-Age(41-60Yrs)
5.749800E-01
Normal-vs-Age(61-80Yrs)
7.239400E-01
Normal-vs-Age(81-100Yrs)
9.727800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.783160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.775000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.543200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.916500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.067000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.948400E-01
Normal-vs-Daily Drinker
7.086800E-01
Normal-vs-Weekly Drinker
5.993800E-01
Normal-vs-Occasional Drinker
4.506200E-01
Normal-vs-Social Drinker
9.914400E-01
Non Drinker-vs-Daily Drinker
4.287800E-01
Non Drinker-vs-Weekly Drinker
4.775400E-01
Non Drinker-vs-Occasional Drinker
2.124000E-03
Non Drinker-vs-Social Drinker
1.586570E-01
Daily Drinker-vs-Weekly Drinker
9.589000E-01
Daily Drinker-vs-Occasional Drinker
3.742300E-02
Daily Drinker-vs-Social Drinker
5.337600E-01
Weekly Drinker-vs-Occasional Drinker
3.825800E-02
Weekly Drinker-vs-Social Drinker
5.055400E-01
Occasional Drinker-vs-Social Drinker
2.003600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.060600E-01
Normal-vs-Grade 2
6.277400E-01
Normal-vs-Grade 3
1.479780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.887760E-01
Grade 1-vs-Grade 3
5.336400E-02
Grade 1-vs-Grade 4
3.060600E-01
Grade 2-vs-Grade 3
1.889580E-01
Grade 2-vs-Grade 4
6.277400E-01
Grade 3-vs-Grade 4
1.479780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.344600E-01
Normal-vs-NonDiabetic
8.758000E-01
Diabetic-vs-NonDiabetic
8.707800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.964000E-01
Normal-vs-NoPancreatitis
8.318200E-01
Pancreatitis-vs-NoPancreatitis
4.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.248600E-01
Normal-vs-N1
8.954600E-01
N0-vs-N1
4.332200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.953400E-01
Normal-vs-TP53-NonMutant
7.255000E-01
TP53-Mutant-vs-TP53-NonMutant
3.418700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
